The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Li-Fraumeni syndrome: cancer risk assessment and clinical management
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 1,008
Kato, S., Han, S.-Y., Liu, W., Otsuka, K., Shibata, H., Kanamaru, R., & Ishioka, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431692100 · Cited by 874
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Bernie, T., Les, I., Paul, G., Jan, K., David, W., & Chris, S. (1998) · BMJ · doi:10.1136/bmj.317.7158.559 · Cited by 811
Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Kauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., Isaacs, C., Evans, D. G., Lynch, H., Eeles, R. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9626 · Cited by 589
Self-citationOlivier, M., Goldgar, D. E., Sodha, N., Ohgaki, H., Kleihues, P., Hainaut, P. L., & Eeles, R. A. (2003) · PubMed · Cited by 576
Self-citationMultiple Primary Cancers in Families With Li-Fraumeni Syndrome
Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 557
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
Michalkiewicz, E., Sandrini, R., Figueiredo, B., Miranda, E. C. M., Caran, E., Oliveira-Filho, A. G., Marques, R., Pianovski, M. A. D., Lacerda, L., Cristofani, L. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.085 · Cited by 519
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
GermlineTP53 mutations and Li-Fraumeni syndrome
Varley, J. M. (2003) · Human Mutation · doi:10.1002/humu.10185 · Cited by 430
Villani, A., Tabori, U., Schiffman, J., Shlien, A., Beyene, J., Druker, H., Novokmet, A., Finlay, J., & Malkin, D. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70119-x · Cited by 423
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., Harris, M., Jones, P. H. M., Binchy, A., & Crowther, D. (1994) · PubMed · Cited by 421
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1167 · Cited by 372
p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
Kemp, C. J., Wheldon, T., & Balmain, A. (1994) · Nature Genetics · doi:10.1038/ng0994-66 · Cited by 368
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Radiation Doses and Cancer Risks from Breast Imaging Studies
Hendrick, R. E. (2010) · Radiology · doi:10.1148/radiol.10100570 · Cited by 360
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols, K. E., Malkin, D. M., Garber, J. E., Fraumeni, J. F., & Li, F. P. (2001) · PubMed · Cited by 354
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Tinat, J., Bougeard, G., Baert-Desurmont, S., Vasseur, S., Martin, C., Bouvignies, E., Caron, O., Bressac-de Paillerets, B., Berthet, P., Dugast, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7967 · Cited by 348
The incidence of secondary leukemias.
Leone, G. G. M., Mele, L., Pulsoni, A., Equitani, F., & Pagano, L. (1999) · PubMed · Cited by 346
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub4 · Cited by 311
Ruijs, M. W. G., Verhoef, S., Rookus, M. A., Pruntel, R., van der Hout, A. H., Hogervorst, F. B. L., Kluijt, I., Sijmons, R. H., Aalfs, C. M., Wagner, A., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.073429 · Cited by 305
Efficacy of a Nationwide Screening Colonoscopy Program for Colorectal Cancer
Pox, C. P., Altenhofen, L., Brenner, H., Theilmeier, A., Stillfried, D. V., & Schmiegel, W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.022 · Cited by 281
Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M., Fraumeni, J. F., & Li, F. P. (1991) · PubMed · Cited by 275
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley, J. M., McGown, G., Thorncroft, M. R., Santibanez‐Koref, M., Kelsey, A. M., Tricker, K. J., Evans, D. G., & Birch, J. M. (1997) · PubMed · Cited by 263
TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
Tabori, U., Shlien, A., Baskin, B., Levitt, S., Ray, P., Alon, N., Hawkins, C., Bouffet, E., Pienkowska, M., Lafay-Cousin, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8169 · Cited by 247
Sarcomas in TP53 germline mutation carriers: A review of the IARC TP53 database
Ognjanovic, S., Olivier, M., Bergemann, T. L., & Hainaut, P. (2012) · Cancer · doi:10.1002/cncr.26390 · Cited by 238
Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
Hwang, S.-J., Lozano, G., Amos, C. I., & Strong, L. C. (2003) · The American Journal of Human Genetics · doi:10.1086/374567 · Cited by 229
Wilms tumour: prognostic factors, staging, therapy and late effects
Kaste, S. C., Dome, J. S., Babyn, P. S., Graf, N. M., Grundy, P., Godzinski, J., Levitt, G. A., & Jenkinson, H. (2008) · Pediatric Radiology · doi:10.1007/s00247-007-0687-7 · Cited by 219
Bougeard, G., Baert-Desurmont, S., Tournier, I., Vasseur, S., Martin, C., Brugieres, L., Chompret, A., Bressac-de Paillerets, B., Stoppa-Lyonnet, D., Bonaiti-Pellie, C., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.037952 · Cited by 217
Leach, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66646-9 · Cited by 213
Heymann, S., Delaloge, S., Rahal, A., Caron, O., Frebourg, T., Barreau, L., Pachet, C., Mathieu, M.-C., Marsiglia, H., & Bourgier, C. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-104 · Cited by 213
Germline mutations in the TP53 gene.
Eeles, R. A. (1995) · PubMed · Cited by 211
Self-citationSurveillance for hereditary nonpolyposis colorectal cancer - A long-term study on 114 families
Cappel, W., Nagengast, F. M., Griffioen, G. G., Menko, F. H., Taal, B. G., Kleibeuker, J. H., & Vasen, H. F. A. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.1097/01.dcr.0000034502.64985.3f · Cited by 204
Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome
Shlien, A., Tabori, U., Marshall, C. R., Pienkowska, M., Feuk, L., Novokmet, A., Nanda, S., Druker, H., Scherer, S. W., & Malkin, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802970105 · Cited by 203
Custódio, G., Parise, G. A., Kiesel Filho, N., Komechen, H., Sabbaga, C. C., Rosati, R., Grisa, L., Parise, I. Z. S., Pianovski, M. A. D., Fiori, C. M. C. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3711 · Cited by 201
Birch, J. M., Blair, V., Kelsey, A. M., Evans, D. G., Harris, M., Tricker, K. J., & Varley, J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202033 · Cited by 200
Pruthi, S., Gostout, B. S., & Lindor, N. M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0414 · Cited by 189
Surveillance for Hereditary Nonpolyposis Colorectal Cancer
de Vos tot Nederveen Cappel, W. H., Nagengast, F. M., Griffioen, G., Menko, F. H., Taal, B. G., Kleibeuker, J. H., & Vasen, H. F. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-7244-3 · Cited by 187
Masciari, S., Dillon, D. A., Rath, M., Robson, M., Weitzel, J. N., Balmana, J., Gruber, S. B., Ford, J. M., Euhus, D., Lebensohn, A., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1993-9 · Cited by 187
Long-term results of screening with magnetic resonance imaging in women with BRCA mutations
Passaperuma, K., Warner, E., Causer, P. A., Hill, K. A., Messner, S., Wong, J. W., Jong, R. A., Wright, F. C., Yaffe, M. J., Ramsay, E. A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.204 · Cited by 183
Rijnsburger, A. J., Obdeijn, I.-M., Kaas, R., Tilanus-Linthorst, M. M. A., Boetes, C., Loo, C. E., Wasser, M. N. J. M., Bergers, E., Kok, T., Muller, S. H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2294 · Cited by 183
Masri, G. D., Clark, W. H., Guerry, D., Halpern, A., Thompson, C. J., & Elder, D. E. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70149-c · Cited by 180
Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer: A Cohort Study
Veronesi, G., Maisonneuve, P., Bellomi, M., Rampinelli, C., Durli, I., Bertolotti, R., & Spaggiari, L. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00005 · Cited by 162
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
Tabori, U. Y., Nanda, S., Druker, H. A., Lees, J., & Malkin, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3682 · Cited by 159
Andreou, D., Bielack, S. S., Carrle, D., Kevric, M., Kotz, R., Winkelmann, W., Jundt, G., Werner, M., Fehlberg, S., Kager, L., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq589 · Cited by 158
Do Surgical Margin and Local Recurrence Influence Survival in Soft Tissue Sarcomas?
Novais, E. N. V., Demiralp, B., Alderete, J. F., Larson, M. C., Rose, P. S., & Sim, F. H. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1471-9 · Cited by 156
Vasen, H. F. A., Wasser, M., van Mil, A., Tollenaar, R. A., Konstantinovski, M., Gruis, N. A., Bergman, W., Hes, F. J., Hommes, D. W., Offerhaus, G. J. A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.048 · Cited by 152
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
Limacher, J., Frébourg, T., Natarajan‐Amé, S., & Bergerat, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1021 · Cited by 151
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
Lustbader, E. D., Williams, W. R., Bondy, M. L., Strom, S. S., & Strong, L. C. (1992) · PubMed · Cited by 148
Gastric cancer in individuals with Li-Fraumeni syndrome
Masciari, S., Dewanwala, A., Stoffel, E. M., Lauwers, G. Y., Zheng, H. W., Achatz, M. I., Riegert‐Johnson, D. L., Foretová, L., da Silva, E. M., DiGianni, L. M., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31821628b6 · Cited by 148
Biology, clinical characteristics, and management of adrenocortical tumors in children
Rodriguez‐Galindo, C., Figueiredo, B. C., Zambetti, G. P., & Ribeiro, R. C. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20318 · Cited by 146
Bacci, G., Ferrari, S. M., Mercuri, M., Bertoni, F., Picci, P., Manfrini, M., Gasbarrini, A., Forni, C., Cesari, M., & Campanacci, M. (1998) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679809000921 · Cited by 139
Local recurrence of localized soft tissue sarcoma
Biau, D. J., Ferguson, P. C., Chung, P. W. M., Griffin, A. M., Catton, C., O’Sullivan, B., & Wunder, J. S. (2012) · Cancer · doi:10.1002/cncr.27639 · Cited by 137
Woodward, E. R., Sleightholme, H., Considine, A., Williamson, S., McHugo, J. M., & Crüger, D. G. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01499.x · Cited by 137
Sorrell, A., Espenschied, C. R., Culver, J. O., & Weitzel, J. N. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0020-0 · Cited by 136
Radiation-sensitive genetically susceptible pediatric sub-populations
Kleinerman, R. A. (2008) · Pediatric Radiology · doi:10.1007/s00247-008-1015-6 · Cited by 135
Ruijs, M., Schmidt, M. K., Nevanlinna, H. A., Tommiska, J., Aittomäki, K., Pruntel, R., Verhoef, S., & Veer, L. J. V. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201715 · Cited by 119
Li, C., Lozano, G., Amos, C. I., Gu, X., Strong, L. C., & Hwang, S. (2003) · Human Genetics · doi:10.1007/s00439-003-0968-7 · Cited by 115
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
Mai, P. L., Malkin, D. M., Garber, J. E., Schiffman, J. D., Weitzel, J. N., Strong, L. C., Wyss, O., Locke, L., Means, V., Achatz, M. I., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.06.008 · Cited by 112
Prevalence of Early Onset Colorectal Cancer in 397 Patients With Classic Li–Fraumeni Syndrome
Wong, P., Verselis, S. J., Garber, J. E., Schneider, K. A., DiGianni, L. M., Stockwell, D. H., Li, F. P., & Syngal, S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.014 · Cited by 111
Lozano, G. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001115 · Cited by 107
Joint Effects of Germ-Line p53 Mutation and Sex on Cancer Risk in Li-Fraumeni Syndrome
Wu, C., Shete, S. S., Amos, C. I., & Strong, L. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4247 · Cited by 101
Masciari, S., den Abbeele, A. D. V., Diller, L., Rastarhuyeva, I., Yap, J., Schneider, K., Digianni, L., Li, F. P., Fraumeni, J. F., Syngal, S., et al. (2008) · JAMA · doi:10.1001/jama.299.11.1315 · Cited by 101
Marcel, V., Palmero, E. I., Falagan-Lotsch, P., Martel‐Planche, G., Ashton‐Prolla, P., Olivier, M., Brentani, H., Hainaut, P. L., & Achatz, M. I. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066704 · Cited by 91
Gopie, J. P., Vasen, H. F. A., & Tibben, A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.01.004 · Cited by 89
Seidinger, A. L., Mastellaro, M. J., Fortes, F. P., Assumpção, J. G., Cardinalli, I. A., Ganazza, M. A., Ribeiro, R. C., Brandalise, S. R., Aguiar, S. D. S., & Yunes, J. A. (2010) · Cancer · doi:10.1002/cncr.25826 · Cited by 83
Abe, M., Miyata, S., Nishimura, S., Iijima, K., Makita, M., Akiyama, F., & Iwase, T. (2009) · Breast Cancer · doi:10.1007/s12282-009-0185-x · Cited by 81
Salmón, A. S., Amikam, D., Sodha, N., Davidson, S., Basel‐Vanagaite, L., Eeles, R. A., Abeliovich, D., & Peretz, T. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.05.001 · Cited by 80
Self-citationHigh Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort
Mitchell, G., Ballinger, M. L., Wong, S. Q., Hewitt, C., James, P. A., Young, M., Cipponi, A., Pang, T. W.-Y., Goode, D. L., Dobrovic, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069026 · Cited by 71
Self-citationRegular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
Lammens, C. R. M., Bleiker, E. M. A., Aaronson, N. K., Wagner, A., Sijmons, R. H., Ausems, M. G. E. M., Vriends, A. H. J. T., Ruijs, M., van Os, T. A. M., Spruijt, L., et al. (2010) · Familial Cancer · doi:10.1007/s10689-010-9368-z · Cited by 70
Gray, J. A. M. (2004) · Europe PMC (PubMed Central) · Cited by 66
The assessment of prognostic factors in surgical treatment of low-grade gliomas: A prospective study
Majchrzak, K., Kaspera, W., Bobek‐Billewicz, B., Hebda, A., Stasik-Pres, G., Majchrzak, H., & Ładziński, P. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.02.054 · Cited by 65
Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival
Morii, Y., Arita, T., Shimoda, K., Yasuda, K., Yoshida, T., & Kitano, S. (2001) · Gastric Cancer · doi:10.1007/pl00011735 · Cited by 64
Trková, M., Procházková, K., Krutilkova, V., Sumerauer, D., & Sedláček, Z. (2007) · Cancer · doi:10.1002/cncr.22834 · Cited by 60
Maheu, C., Vodermaier, A., Rothenmund, H., Gallinger, S., Ardiles, P., Semotiuk, K., Holter, S., Thayalan, S., & Esplen, M. J. (2010) · Familial Cancer · doi:10.1007/s10689-010-9354-5 · Cited by 59
Beyond Li-Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations
Gonzalez, K. D., Noltner, K., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Ngyuen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.11031 · Cited by 58
Glioblastoma multiforme with long term survival
Sarkar, C., Deb, P., Sharma, M., Mahapatra, A., & Agarwal, D. (2005) · Neurology India · doi:10.4103/0028-3886.16934 · Cited by 57
Kriege, M., Brekelmans, C. T. M., Peterse, H. L., Obdeijn, I. M., Boetes, C., Zonderland, H. M., Muller, S. H., Kok, T., Manoliu, R. A., Besnard, A. P. E., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9341-6 · Cited by 45
Clinical Management of Hereditary Breast Cancer Syndromes
Clark, A. S., & Domchek, S. M. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9200-x · Cited by 44
Cappell, M. S., & Goldberg, E. S. (1992) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199204000-00008 · Cited by 43
Fang, S., Krahe, R., Lozano, G., Han, Y., Chen, W., Post, S. M., Zhang, B., Wilson, C. D., Bachinski, L. L., Strong, L. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010813 · Cited by 43
Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?
Trková, M., Hladíková, M., Kasal, P., Goetz, P., & Sedláček, Z. (2002) · Journal of Human Genetics · doi:10.1007/s100380200055 · Cited by 42
Henry, E., Villalobos, V. M., Million, L., Jensen, K. C., West, R. B., Ganjoo, K. N., Lebensohn, A., Ford, J. M., & Telli, M. L. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0097 · Cited by 35
Update on effects of screening mammography
Tabár, L. K., Smith, R. A., & Duffy, S. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09523-5 · Cited by 32
Wu, C., Krahe, R., Lozano, G., Zhang, B., Wilson, C. D., Jo, E.-J., Amos, C. I., Shete, S. S., & Strong, L. C. (2011) · Human Genetics · doi:10.1007/s00439-011-0957-1 · Cited by 32
on behalf of the UK Study Group for MRI Screening in Women at High Risk Study, Hutton, J., Walker, L. G., Gilbert, F. J., Evans, D. G., Eeles, R. A., Kwan-Lim, G. E., Thompson, D., Pointon, L. J., Sharp, D. M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.1 · Cited by 31
Self-citationFerrarini, A., Auteri-Kaczmarek, A., Pica, A., Boesch, N., Heinimann, K., Schäfer, S. C., Mégalo, S. V., Cina, V., Beckmann, J. S., & Monnerat, C. (2011) · Familial Cancer · doi:10.1007/s10689-010-9415-9 · Cited by 25
Harinck, F., Poley, J., Kluijt, I., Fockens, P., & Bruno, M. J. (2010) · Digestive Diseases · doi:10.1159/000320095 · Cited by 19
Adrenocortical Carcinoma: Basic Science and Clinical Concepts
Terzolo, M., Ardito, A., Zaggia, B., FRANCIA, S. D., & Daffara, F. (2010) · Springer eBooks · doi:10.1007/978-0-387-77236-3 · Cited by 8
Cited by
Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., Gauthier-Villars, M., Stoppa-Lyonnet, D., Consolino, E., Brugières, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5728 · Cited by 760
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Sperling, A. S., Gibson, C. J., & Ebert, B. L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.112 · Cited by 678
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534
Metadata
- Authors
- McBride, K. A., Ballinger, M. L., Killick, E., Kirk, J., Tattersall, M. H. N., Eeles, R. A., Thomas, D. M., & Mitchell, G.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2014-03-18
- Volume
- 11
- Issue
- 5
- Pages
- 260-271
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2070243390
- Cited by
- 281
- References
- 113
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.